Reliable segregation of survival under immunotherapy in NSCLC using simple clinical parameters.

14. September 2026

P. Christopoulos, M. Sebastian, W. Eberhardt, A. Rittmeyer, M. Reck, J. Alt, K. Kokowski, P. Sadjadian, D. Heigener, K. Schneider, A. Fleitz, M. Jänicke, P. Ludwig, M. Groschek, M.-O. Zahn, T. Dechow, T. Fietz, H. Pelz, F. Griesinger, M. Thomas.

Oncol Res Treat 2026;49(suppl 1):10–335

Poster